Updated HER2 In Situ Hybridization (ISH) Guidelines in Breast Cancer: Some Equivocal Findings

被引：0
|
作者：
Kos, Zuzana [1 ]
Craddock, Kenneth [1 ]
Berman, Hal [1 ]
Done, Susan [1 ]
Miller, Naomi [1 ]
Youngson, Bruce [1 ]
Mulligan, Anna Marie [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
194
引用
收藏
页码：51A / 52A
页数：2
相关论文
共 50 条
  • [21] Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer
    Guo, Lei
    Yuan, Pei
    Zhang, Jing
    Ling, Yun
    Li, Wenbin
    Zhao, Bohui
    Ying, Jianming
    Xuan, Lixue
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 77 - 84
  • [22] Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer
    Lei Guo
    Pei Yuan
    Jing Zhang
    Yun Ling
    Wenbin Li
    Bohui Zhao
    Jianming Ying
    Lixue Xuan
    Breast Cancer Research and Treatment, 2017, 166 : 77 - 84
  • [23] Comparison of Fluorescence In Situ Hybridization (FISH) and Dual-ISH (DISH) in the Determination of HER2 Status in Breast Cancer
    Mansfield, Aaron S.
    Sukov, William R.
    Eckel-Passow, Jeanette E.
    Sakai, Yuta
    Walsh, Frank J.
    Lonzo, Melissa
    Wiktor, Anne E.
    Dogan, Ahmet
    Jenkins, Robert B.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (02) : 144 - 150
  • [24] HER2 testing in metastatic breast cancer-Is reflex ISH testing necessary on HER2 IHC-equivocal (2+) cases?
    Liwski, Christopher R.
    Castonguay, Mathieu C.
    Barnes, Penny J.
    Rayson, Daniel
    Bethune, Gillian C.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 59
  • [25] Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization:: a technical review with interpretive guidelines
    Hicks, DG
    Tubbs, RR
    HUMAN PATHOLOGY, 2005, 36 (03) : 250 - 261
  • [26] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Wang, Bo
    Ding, Wei
    Sun, Ke
    Wang, Xiaoling
    Xu, Liming
    Teng, Xiaodong
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [27] Correlation of In Situ HER2 RNA Expression With HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Categories in Breast Cancer
    Tseng, Yu-Fen
    Li, Yu-Chia
    Lee, Yi-Hsuan
    Hu, Hsiang-We
    Zhang, Man-San
    Hung, Tze-Chun
    Lien, Huang-Chun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (03) : e48 - e56
  • [28] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Bo Wang
    Wei Ding
    Ke Sun
    Xiaoling Wang
    Liming Xu
    Xiaodong Teng
    Scientific Reports, 9
  • [29] Chromogen in situ hybridization of imunohistochemical HER2 equivocal invasive breast carcinomas: One year of experience
    Lazureanu, D.
    Dema, A.
    Muresan, A.
    Vaduva, A.
    Derban, M.
    Vita, C.
    VIRCHOWS ARCHIV, 2014, 465 : S119 - S119
  • [30] Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer A Cohort Study Emphasizing Equivocal Cases
    Shao, Tiffany
    Wood, Martha
    Wing, Anthony
    Hnatovska, Marta
    Mendes, Maria
    Mullen, J. Brendan
    Chang, Martin C.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (03) : 339 - 345
12345